Seqcoast Genomics, LLC

Portsmouth, NH Part of Oakhurst Biosciences, Inc.

UEI
P7FFRKSCXMD5
CAGE
9ZCR8
Primary NAICS
541380 Testing Laboratories and Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
25 New Hampshire Ave #205, Portsmouth, NH 03801, USA
Website
seqcoast.com
Founded
2022
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Seqcoast Genomics, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Nhgri: Contract · 75N98026P01384 Office of Logisitics and Acquisition Operations $21,400
The laboratory of julie segre (tfgb/MGS) studies the human skin microbiome. The lab prepares skin commensal organisms… Contract · 75N98026P00779 Office of Logisitics and Acquisition Operations $21,400
Abbl - davies - metagenomic sequencing of 192 PIG fecal and digesta samples. Perform DNA metagenomic sequencing of… Contract · 1232SA25P0542 Central Program Planning Coordination and Support $14,974
Custom sequencing services Contract · 1232SA25P0240 Central Program Planning Coordination and Support $18,874
Non-human whole genome sequencing bundle, 2X150BP, 1 GB per sample, value package Contract · 12305B24P0179 Northeast Area $11,190

About Seqcoast Genomics, LLC

Seqcoast Genomics, LLC, a Portsmouth, New Hampshire-based genomic sequencing services provider, operates as a prime contractor delivering DNA metagenomic sequencing, whole genome sequencing, and multi-omics analytical services to federal research agencies. The company is a child entity of parent Oakhurst Biosciences, Inc., also based at 25 New Hampshire Ave #205, Portsmouth.

Seqcoast operates across two primary service lines: shotgun sequencing using Illumina platforms (NovaSeq X Plus, HiSeq, Illumina Flex) for high-volume metagenomic work on environmental and biological samples, and broader multi-omics analytical services including metabolomics, proteomics, transcriptomics, and genomics analysis. Recent representative work includes a $14,974.08 purchase order from USDA Agricultural Research Service Northeast Area (awarded October 2025) for DNA metagenomic sequencing of 192 pig fecal and digesta samples using Illumina Flex and NovaSeq X Plus technology, a $21,400.32 purchase order from the National Human Genome Research Institute (awarded August 2026) supporting Julie Segre's laboratory studies of the human skin microbiome involving strain sharing and microbial genome sequencing, and a $11,189.50 small-business set-aside purchase order from USDA ARS Northeast Area (awarded September 2024) for non-human whole genome sequencing of 175 bacterial genome samples.

Customer concentration is diffuse across research-focused agencies. The Department of Agriculture's Agricultural Research Service Northeast Area has placed three awards ($45 thousand combined potential value), the National Institutes of Health's National Human Genome Research Institute has placed one award ($21 thousand), and the Army Corps of Engineers Engineer Research and Development Center has placed one award ($500 thousand). The ERDC award, a multiple-award Blanket Purchase Agreement valued at $500 thousand with performance through September 2030, was awarded September 2025 and establishes standing availability for multi-omics characterization services supporting the Cold Regions Research and Engineering Laboratory's biogeochemical research, with initial work projected to span approximately 86 transcriptomics samples across two batches.

Activity has accelerated modestly — one award in 2024, three in 2025, one in 2026 — across a small portfolio totaling five prime awards with combined potential value of $566 thousand. Two awards (combined potential value $36 thousand) face completion within the next twenty-four months and therefore expose the vendor to recompete activity. The vendor holds no sub-awards and does not appear on larger prime contractors' teams in the source data. Seqcoast competes full-and-open; none of its recent awards carry small-business set-asides except for two USDA ARS purchases in 2024–2025 designated as Total Small Business set-asides.

Quick answers

What is Seqcoast Genomics, LLC's UEI?

Seqcoast Genomics, LLC's Unique Entity ID (UEI) in SAM.gov is P7FFRKSCXMD5.

What is Seqcoast Genomics, LLC's CAGE code?

Seqcoast Genomics, LLC's CAGE code is 9ZCR8.

What is Seqcoast Genomics, LLC's primary NAICS code?

Seqcoast Genomics, LLC's primary NAICS code is 541380 (Testing Laboratories and Services).

Where is Seqcoast Genomics, LLC located?

Seqcoast Genomics, LLC's physical address in SAM.gov is 25 New Hampshire Ave #205, Portsmouth, NH 03801, USA.

Is Seqcoast Genomics, LLC registered in SAM.gov?

Yes. Seqcoast Genomics, LLC's SAM.gov registration is active through December 13, 2026.

Who is Seqcoast Genomics, LLC's parent company?

Seqcoast Genomics, LLC is part of Oakhurst Biosciences, Inc.

What is Seqcoast Genomics, LLC's most recent federal award?

Seqcoast Genomics, LLC's most recent federal contract award is Nhgri: (75N98026P01384), from Office of Logisitics and Acquisition Operations, on September 3, 2026.

On GovTribe

See Seqcoast Genomics, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors